Related references
Note: Only part of the references are listed.Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy
Yukihiko Kawasaki et al.
PEDIATRICS INTERNATIONAL (2018)
Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy
Chang-Yun Yoon et al.
ANNALS OF MEDICINE (2017)
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
Mark Haas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial
Jicheng Lv et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy
Shubha S. Bellur et al.
KIDNEY INTERNATIONAL (2017)
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
Hernan Trimarchi et al.
KIDNEY INTERNATIONAL (2017)
Updated Oxford Classification of IgA nephropathy: a new MEST-C score
Glen Markowitz
NATURE REVIEWS NEPHROLOGY (2017)
Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis
Sanjeev Sethi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy
Teodora Ioana Flavia Paunas et al.
CLINICAL PROTEOMICS (2017)
Candidate Surrogate End Points for ESRD after AKI
Morgan E. Grams et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Diagnosis and treatment of patients with IgA nephropathy in Japan
Yasuhiko Tomino
KIDNEY RESEARCH AND CLINICAL PRACTICE (2016)
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
Thomas Rauen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Sublytic C5b-9 induces IL-6 and TGF-β1 production by glomerular mesangial cells in rat Thy-1 nephritis through p300-mediated C/EBPβ acetylation
Jing Zhang et al.
FASEB JOURNAL (2014)
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy
Roland Schmitt et al.
JOURNAL OF IMMUNOLOGY (2014)
Is a decline in estimated GFR an appropriate surrogate end point for renoprotection drug trials?
Steven J. Rosansky et al.
KIDNEY INTERNATIONAL (2014)
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Rosanna Coppo et al.
KIDNEY INTERNATIONAL (2014)
New insights into the pathogenesis of IgA nephropathy
Jurgen Floege et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
Shen-Ju Gou et al.
KIDNEY INTERNATIONAL (2013)
Recent insights into C3 glomerulopathy
Thomas D. Barbour et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
Houda Tamouza et al.
KIDNEY INTERNATIONAL (2012)
Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy
Seung Jun Kim et al.
PLOS ONE (2012)
The Pathophysiology of IgA Nephropathy
Hitoshi Suzuki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function
Kisara Onda et al.
BMC NEPHROLOGY (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
Daniel C. Cattran et al.
KIDNEY INTERNATIONAL (2009)
Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy
Kar Neng Lai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Activation of podocytes by mesangial-derived TNF-α:: glomerulo-podocytic communication in IgA nephropathy
Kar Neng Lai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Complement 3 is involved in changing the phenotype of human glomerular mesangial cells
Jian-Xin Wan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
IgACE:: A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria
Rosanna Coppo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease
A Roos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Cellular response to injury in membranous nephropathy
M Nangaku et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial
C Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
DNA damage is a novel response to sublytic complement CSb-9-induced injury in podocytes
JW Pippin et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Prognostic indicators of IgA nephropathy in the Chinese - clinical and pathological perspectives
PKT Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy
K Abe et al.
NEPHRON (2001)
Complement-induced phospholipase A2 activation in experimental membranous nephropathy
AV Cybulsky et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
